Posted inCritical Care Infectious Diseases news
Harnessing Precision Medicine: The APS Consortium’s National Platform for Phenotyping ARDS, Pneumonia, and Sepsis
The APS Consortium establishes a large, prospective cohort of critically ill adults with ARDS, pneumonia, and sepsis to enable biologically based phenotyping, leveraging rich clinical data and biospecimens for improved understanding and therapeutic development.


